Loading…

Characterization of the UL10 gene product of herpes simplex virus type 1 and investigation of its role in vivo

MRC Virology Unit, Institute of Virology, University of Glasgow, Church Street, Glasgow G11 5JR, U.K. On the basis of predicted amino acid sequence characteristics, herpes simplex virus type 1 gene UL10 is thought likely to encode a membrane protein with eight potential transmembrane regions. Previo...

Full description

Saved in:
Bibliographic Details
Published in:Journal of general virology 1993-06, Vol.74 (6), p.975-983
Main Authors: MacLean, Christine A, Robertson, Lesley M, Jamieson, Fiona E
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:MRC Virology Unit, Institute of Virology, University of Glasgow, Church Street, Glasgow G11 5JR, U.K. On the basis of predicted amino acid sequence characteristics, herpes simplex virus type 1 gene UL10 is thought likely to encode a membrane protein with eight potential transmembrane regions. Previously, a protein with an apparent M r 47 000 on SDS-PAGE was identified as a product of this gene. Here we have further characterized this protein, and show that it is modified by N -linked glycosylation, associates with membranes from infected cells, and is a component of the virus particle. It is not essential for virus growth in tissue culture. To investigate its role in vivo a deletion mutant lacking the majority of the UL10 open reading frame was constructed ( UL10-del ). The in vitro growth properties of this virus were consistent with previous studies; it grew to give slightly lower yields than wild-type and revertant viruses, and had no apparent temperature-sensitive or host range phenotype. In vivo , in a mouse model, UL10-del was capable of establishing a latent infection, although it was impaired for growth at the periphery, and for spread to and/or growth within the nervous system relative to wild-type or revertant viruses. Present address: Department of Pharmaceutical Science, Royal College, University of Strathclyde, 204 George Street, Glasgow G1 1XW, U.K. Received 12 November 1992; accepted 26 January 1993.
ISSN:0022-1317
1465-2099
DOI:10.1099/0022-1317-74-6-975